Albanimmo SRL
Albanimmo reported total assets of €2.53m at the end of the 2025 financial year (annual accounts filed with the NBB on 22 Aug 2026).
The score of Albanimmo shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +330 % Total assets +286 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Albanimmo's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Aug 2026
- Year ended 31 Dec 2024filed on 28 Sep 2025
- Year ended 31 Dec 2023filed on 15 Oct 2024
- Year ended 31 Dec 2022filed on 25 Dec 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Albanimmo's financial analysis
- Solvency39.7%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Albanimmo
Albanimmo's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0667.765.123
- VAT number
- BE0667765123
- Peppol
- Registered · 0208:0667765123 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 15 Dec 2016
- Registered office
- 1390 Grez-Doiceau
- Latest accounts
- 2025 · filed on 22 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Albanimmo (SRL) has been based in Grez-Doiceau since 2016, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 768,137 € and equity of €1.00m; its revenue is not published. Its solvency stands at 39.7%, below the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Albanimmo
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Demeulenaere Retail sale of pharmaceutical products Retie · balance sheet €2.57m
- Edis Invest Retail sale of pharmaceutical products Molenbeek-Saint-Jean · balance sheet €2.26m
- Limafran Retail sale of pharmaceutical products Lincent · balance sheet €2.00m
- Medifarm+ Retail sale of pharmaceutical products Bruges · balance sheet €2.75m
- Pharmacie du Bon Pasteur Retail sale of pharmaceutical products Mons · balance sheet €3.67m
- Parapharmacie Discount Andenne Retail sale of pharmaceutical products Andenne · balance sheet €1.34m
- Apotheker Steven Vrijdag Retail sale of pharmaceutical products Dendermonde · balance sheet €1.32m
- Trimephar Retail sale of pharmaceutical products Faimes · balance sheet €1.30m
Frequently asked questions about Albanimmo
What is the revenue of Albanimmo?
Albanimmo files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Albanimmo?
In Belgium, the VAT number is the company number prefixed with BE: BE0667765123 for Albanimmo, if the company is VAT-registered. Its company number (CBE) is 0667.765.123.
Where is the registered office of Albanimmo?
According to the CBE register, the registered office of Albanimmo is in 1390 Grez-Doiceau.
What is the equity of Albanimmo?
At the close of the 2025 financial year, the equity of Albanimmo amounts to 1,004,068 €, a solvency of 39.7% of total assets.
Who manages Albanimmo?
The register lists 3 active mandates at Albanimmo. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Albanimmo
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →